Zhang et al. designed LYN-1604, an agonist of the autophagy gene ULK1, which can induce ATG5-dependent autophagic death in triple-negative breast carcinoma cells by activating the ULK complex [71]. Here, ATG5 is linked to triple-negative breast carcinoma.